Medical devices

United States Lithotripsy Devices Market Prospects, Trends Analysis, Market Size and Forecasts up to 2025 - ResearchAndMarkets.com

Retrieved on: 
Monday, October 28, 2019
Medical devices, Health, Economy, Finance, Money, Marketing, Lithotripsy, Market trend

The "United States Lithotripsy Devices Market: Prospects, Trends Analysis, Market Size and Forecasts up to 2025" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "United States Lithotripsy Devices Market: Prospects, Trends Analysis, Market Size and Forecasts up to 2025" report has been added to ResearchAndMarkets.com's offering.
  • The country research report on United States lithotripsy devices market is a customer intelligence and competitive study of the United States market.
  • Moreover, the report provides deep insights into demand forecasts, market trends, and, micro and macro indicators in the United States market.
  • 5) What are the modes of entering United States lithotripsy devices market?

Castle Biosciences Presents Second Study Confirming Ability of DecisionDx-Melanoma to Inform Sentinel Lymph Node Biopsy Decisions at the 8th International Congress on Cancer Metastasis

Retrieved on: 
Monday, October 28, 2019
Biotechnology, FDA, Health, Pharmaceutical, Surgery, Oncology, Other Science, Research, Medical devices, General Health, Hospitals, Genetics, Science, Clinical trials, Medicine, Medical specialties, Clinical medicine, RTT, Cancer, Melanoma, Sentinel lymph node, Lymph node, Micrometastasis, Gamma probe, DecisionDx-Melanoma, Castle Biosciences

The study found that DecisionDx-Melanoma test results can be used with clinicopathologic factors to identify patients at low risk of sentinel lymph node (SLN) positivity.

Key Points: 
  • The study found that DecisionDx-Melanoma test results can be used with clinicopathologic factors to identify patients at low risk of sentinel lymph node (SLN) positivity.
  • This information can inform patient discussions and recommendations regarding the SLNB surgical procedure in line with national melanoma clinical practice guidelines.
  • National guidelines recommend the SLNB surgical procedure to assess prognosis of melanoma patients whose tumor features suggest at least a 5% likelihood of sentinel lymph node (SLN) positivity.
  • The guidelines do not recommend the procedure if a patient has a likelihood of SLN positivity of less than 5%.

Global Body Area Network Market 2019-2025 | Analysis by Device Type, Component, Application and Region - ResearchAndMarkets.com

Retrieved on: 
Monday, October 28, 2019
Medical devices, Health, Companies, Industries, Economy of South Korea, Samsung Electronics, Videotelephony, Samsung, Apple Inc.

The "Global Body Area Network Market (2019-2025)" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "Global Body Area Network Market (2019-2025)" report has been added to ResearchAndMarkets.com's offering.
  • The Global Body Area Network Market size is expected to reach $17 billion by 2025, rising at a market growth of 11.6% CAGR during the forecast period.
  • The impact of technologies on recent advances in the healthcare industry has laid the foundation for stake holders in the market of body area network.
  • Based on the Analysis presented in the Cardinal matrix, Samsung Electronics Co., Ltd. and Apple, Inc. are some of the forerunners in the Body Area Network Market.

Global Operating Room/OR Integration Market 2019-2024 | Analysis by Component, Application, End-user and Region - ResearchAndMarkets.com

Retrieved on: 
Monday, October 28, 2019
Hospitals, Health, Medical devices, Fields of mathematics, Actuarial science, Compound annual growth rate, Mathematical finance, Non-Newtonian calculus, Academic disciplines, Security, Physical security information management, Draft:Surendra

The operating room integration market is projected to reach USD 1,731.6 million by 2024 from USD 964.7 million in 2019, at a CAGR of 12.4%.

Key Points: 
  • The operating room integration market is projected to reach USD 1,731.6 million by 2024 from USD 964.7 million in 2019, at a CAGR of 12.4%.
  • In this report, the OR integration market has been segmented on the basis of component, application, end-user, and region.
  • In 2018, the general surgery segment accounted for the largest share of the operating room integration market.
  • The operating room integration market in the RoW is expected to witness the highest CAGR during the forecast period.

NovaBay Pharmaceuticals to Distribute the NuLids System® for the Treatment of Dry Eye in Certain U.S. Geographies

Retrieved on: 
Monday, October 28, 2019
Medical devices, Infectious diseases, Health, Pharmaceutical, Optical, Medical specialties, Medicine, Ophthalmology, Blepharitis, RTT, Meibomian gland, Eyelid, Eyelash, Dry eye syndrome, Optometry, Blepharoplasty, BlephEx, NovaBay Pharmaceuticals, Inc.: Going Beyond Antibiotics®, NuSight Medical®: Comfort in the Blink of an Eye

The NuLids System is a hand-held, cordless device that safely and effectively removes accumulated scurf from eyelashes and eyelids, while stimulating meibomian gland production in dry eye and blepharitis patients.

Key Points: 
  • The NuLids System is a hand-held, cordless device that safely and effectively removes accumulated scurf from eyelashes and eyelids, while stimulating meibomian gland production in dry eye and blepharitis patients.
  • We further believe the NuLids System will elevate our sales calls with ophthalmologists and optometrists and make our salespeople more productive.
  • We expect to begin selling the NuLids System at the beginning of November in the greater mid-Atlantic region.
  • The NuLids System is the unique, patented, mechanical device that is directed by eye care practitioners for the home-based treatment of Dry Eye Disease and Blepharitis.

Advanced Sterilization Products Unveils New Brand Strategy

Retrieved on: 
Monday, October 28, 2019
Surgery, Medical devices, Infectious diseases, Health, Medical Supplies, Chemical substances, Medical specialties, Health, Infectious diseases, Antiseptics, Disinfectants, Electron beam, Sterilization, Infection control, Hospital-acquired infection, Hydrogen peroxide, Vaporized hydrogen peroxide

Advanced Sterilization Products (ASP) announced today its new brand strategy with a refreshed mission, new logo, and a redesigned website.

Key Points: 
  • Advanced Sterilization Products (ASP) announced today its new brand strategy with a refreshed mission, new logo, and a redesigned website.
  • ASP, a pioneer of low-temperature hydrogen peroxide sterilization technology , provides infection prevention technologies that protect patients from hospital acquired infections.
  • The vertical lines of the new ASP brand are inspired by the process of sterilization and convey acceleration and progress, signifying the advancement and innovation ASP continuously drives toward.
  • Advanced Sterilization Products (ASP) has a long track record of designing and delivering innovative infection prevention solutions that dramatically raise the level of health care and safety for those who matter most.

Fresenius Medical Care Celebrates 10th Anniversary and Expansion of Their Dialysis Center With Enhanced Home Therapy Support in Perth, Western Australia

Retrieved on: 
Monday, October 28, 2019
Medical Supplies, Health, Medical devices, Practice Management, Other Health, General Health, Biotechnology, Health, Medicine, Membrane technology, Fresenius, Societates Europaeae, Renal dialysis, Home hemodialysis, Dialysis, Therapy, Ulf Mark Schneider

Fresenius Medical Care, the world's leading provider of dialysis products and services, announced the further enhancement of support for home dialysis patients in Western Australia.

Key Points: 
  • Fresenius Medical Care, the world's leading provider of dialysis products and services, announced the further enhancement of support for home dialysis patients in Western Australia.
  • Celebrating the 10th anniversary of the Fresenius Kidney Care Spearwood Dialysis Clinic in Perth this year, Fresenius Medical Care has expanded the facility with the addition of three home dialysis training rooms.
  • The Fresenius Medical Care management team, staff and patients celebrate 10th anniversary and expansion of Fresenius Kidney Care Spearwood Clinic with enhanced home therapy support in Perth, Western Australia.
  • Fresenius Medical Care has been working with local healthcare professionals, authorities and communities to help address this issue.

A Decade of Innovation and Growth: Cook Korea 10th Anniversary

Retrieved on: 
Monday, October 28, 2019
Professional services, Medical Supplies, Health, Medical devices, Hospitals, Surgery, Consulting, Cook Group, USS Donald Cook, Cook, Economy of the United States

Cook Medical celebrated its 10-year anniversary with a special event that marked a major milestone a decade of successful customer service, innovation and employee development.

Key Points: 
  • Cook Medical celebrated its 10-year anniversary with a special event that marked a major milestone a decade of successful customer service, innovation and employee development.
  • View the full release here: https://www.businesswire.com/news/home/20191027005047/en/
    Cook Korea celebrates a decade of commitment to local staff and community with a traditional drum performance.
  • The Cook Korea company as we now know it was established in 2009.
  • Pete Yonkman, President, Cook Group and Cook Medical, said during the anniversary celebration, We are incredibly proud of our office in Korea.

Georgia Bio Statement on BD Sterilization Plant In Georgia;

Retrieved on: 
Friday, October 25, 2019
Medical Supplies, Health, Chemicals, Plastics, Medical devices, Environment, Manufacturing, General Health, Healthcare quality, Patient safety, Articles, Health

Georgia Bio member companies are dedicated to improving patients lives-enhancing patient safety and expanding patient access to innovative treatments.

Key Points: 
  • Georgia Bio member companies are dedicated to improving patients lives-enhancing patient safety and expanding patient access to innovative treatments.
  • Ethylene oxide is the safest, and sometimes, only method for ensuring the sterilization of medical devices for clinicians and patients.
  • Georgia Bio member companies are dedicated to improving patients lives enhancing patient safety and expanding patient access to innovative treatments.
  • Georgia Bio members include bioscience and medtech companies, academic and research institutions, life science service providers, digital health companies, and related organizations.

PerkinElmer to Present at Wolfe Research Healthcare Conference

Retrieved on: 
Friday, October 25, 2019
Biotechnology, Pharmaceutical, Health, Medical devices, PerkinElmer, New York Stock Exchange, Pe, Economy of the United States, Companies, Economy of New York City

PerkinElmer, Inc. (NYSE: PKI), a global leader committed to innovating for a healthier world, today announced that the Company will present at the Wolfe Research Healthcare Conference on Wednesday, November 6, 2019, at 8:00 a.m.

Key Points: 
  • PerkinElmer, Inc. (NYSE: PKI), a global leader committed to innovating for a healthier world, today announced that the Company will present at the Wolfe Research Healthcare Conference on Wednesday, November 6, 2019, at 8:00 a.m.
  • Prahlad Singh, PerkinElmers president and chief operating officer, will provide an overview of the Company and its strategic priorities.
  • A replay of the presentation will be posted on the PerkinElmer website after the event and will be available for 90 days following.
  • PerkinElmer, Inc. is a global leader focused on innovating for a healthier world.